<DOC>
	<DOCNO>NCT00517894</DOCNO>
	<brief_summary>To investigate dose-dense chemotherapy weekly chemotherapy compare standard treatment every 3 week result well survival aggressive non-Hodgkin 's lymphoma .</brief_summary>
	<brief_title>Dose-Dense Therapy Aggressive Lymphoma</brief_title>
	<detailed_description>Patients randomize receive dose-dense CEOP/IMVP-Dexa chemotherapy standard 3-weekly CHOP .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<criteria>18 70 year age Centrally review , histologically prove diffuse large Bcell , anaplastic largecell , peripheral Tcell unspecified Measurable disease All stag Lymphoblastic Burkitt histology CNSdisease HIVpositive pregnant lactate woman Pretreatment Other malignancy Concomitant diseases forbid chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>lymphoma</keyword>
	<keyword>aggressive</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>dose-dense</keyword>
</DOC>